The targeted delivery of chemotherapy drugs to tumor lesions is a major challenge for the treatment of tumors. Up until now, various polymeric nanoparticles have been explored to improve the targetability of these therapeutic drugs through passive or active targeting processes. In the design and construction of polymer nanoparticles, glycopolypeptide has shown great potential owing to its excellent targeting ability and biocompatibility. In order to enhance the antitumor effect of doxorubicin (DOX), a glycopolypeptide-based micelle (GPM) modified by α-lactose (Lac) was synthesized for targeted treatment of hepatoma. The DOX-loaded GPM (i.e., GPM/DOX) could significantly target human hepatoma (HepG2) cells and further inhibit their proliferation in vitro. Additionally, GPM/DOX exhibited a much higher drug accumulation in tumor tissue and a stronger antitumor effect in vivo than free DOX. The above results revealed that this drug delivery system provides a promising platform for the targeting therapy of hepatic cancer.

Thermosensitive gels are commonly used as drug carriers in medical fields, mainly due to their convenient processing and easy functionalization. However, their overall performance has been severely affected by their unsatisfying biocompatibility and biodegradability. To this end, we synthesized poly(l-alanine) (PLAla)-based thermosensitive hydrogels with different degrees of polymerization by ring-opening polymerization. The obtained mPEG₄₅−PLAla copolymers showed distinct transition temperatures and degradation abilities. It was found that slight changes in the length of hydrophobic side groups had a decisive effect on the gelation behavior of the polypeptide hydrogel. Longer hydrophobic ends led to a lower gelation temperature of gel at the same concentration, which implied better gelation capability. The hydrogels showed rapid gelling, enhanced biocompatibility, and better degradability. Therefore, this thermosensitive hydrogel is a promising material for biomedical application.

Non-specific biofilm formation (biofouling) commonly occurs to the surface of biomedical devices, which causes infection to the human tissues and function loss after implantation. To enhance the antifouling properties on the bioinert hydrogel-based biomaterials, a novel surface grafting approach was developed using surface radical chain-transfer reaction mediated by DL-dithiothreitol (DTT), rather than catalyzed by cytotoxic metal ions. Zwitterionic poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC) brushes were grafted on the surface of poly(2-hydroxyethyl methacrylate-co-glycidyl methacrylate) (PHG) to obtain PHG-graft-PMPC (PHG-g-PMPC) hydrogel, which were shown to have tunable surface hydrophilicity while maintaining high water content and transparency. Elemental composition analysis and micromorphology demonstrated the success of surface grafting. Protein adhesion assays were carried out, showing the reduction of bovine serum albumin, lactoferrin, and lysozyme adhesion by ∼90%, 80%, and 70%, respectively, compared to the pristine hydrogels. Significant resistance of bacterial attachment was observed on the surface-modified hydrogels using gram-negative Escherichia. coli and gram-positive Staphylococcus aureus, respectively. The PHG-g-PMPC hydrogel is potentially feasible in various biomedical applications, especially for preventing surface biofouling of ophthalmic implants and devices. Furthermore, this de novo approach provides a universal platform for surface functionalization via thiol-epoxy click chemistry and surface radical chain-transfer reaction.